Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SARECYCLINE vs SAXAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SARECYCLINE vs SAXAGLIPTIN: Safety Overview

Metric SARECYCLINE SAXAGLIPTIN
Total FAERS Reports 134 2,468
Deaths Reported 0 263
Death Rate N/A 10.7%
Hospitalizations 11 838
Average Patient Age 29.1 yrs 65.5 yrs
% Female Patients 53.5% 47.8%
FDA Approval Date Oct 1, 2018 Jul 31, 2009
Manufacturer Almirall, LLC Glenmark Pharmaceuticals Inc., USA
Route ORAL ORAL
Marketing Status Prescription Discontinued